ReviewAntibodies (Basel, Switzerland)2025

Adoptive Cell Immunotherapy in Relapse/Refractory Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disorders.

Martina Canichella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.